Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Jimenez-Yuste

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|August 22, 2015
Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settingsRafael Parra Lopez, Laszlo Nemes, Victor Jimenez-Yuste, et al.
The New England Journal of Medicine|January 31, 2023
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia AAnnette von Drygalski, Pratima Chowdary, Roshni Kulkarni, et al.
Hemasphere|June 12, 2023
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice GuidanceRoger E G Schutgens, Victor Jimenez-Yuste, Miguel Escobar, et al.
Expert Review of Hematology|December 23, 2022
Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathiesNuria Blazquez-Ramos, José A Romero-Garrido, Luis Gonzalez Del Valle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2020
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diaryAndreas Tiede, Santiago Bonanad, Amparo Santamaria, et al.
Therapeutic Advances in Hematology|May 8, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS StudyDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2022
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working GroupRobert Klamroth, Cihan Ay, Philippe De Moerloose, et al.
Thrombosis and Haemostasis|February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect StudyRi J Liesner, Aby Abraham, Carmen Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical AppraisalManuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand DiseaseMark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|August 22, 2015
Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settingsRafael Parra Lopez, Laszlo Nemes, Victor Jimenez-Yuste, et al.
The New England Journal of Medicine|January 31, 2023
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia AAnnette von Drygalski, Pratima Chowdary, Roshni Kulkarni, et al.
Hemasphere|June 12, 2023
Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice GuidanceRoger E G Schutgens, Victor Jimenez-Yuste, Miguel Escobar, et al.
Expert Review of Hematology|December 23, 2022
Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathiesNuria Blazquez-Ramos, José A Romero-Garrido, Luis Gonzalez Del Valle, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 21, 2020
Quality of electronic treatment records and adherence to prophylaxis in haemophilia and von Willebrand disease: Systematic assessments from an electronic diaryAndreas Tiede, Santiago Bonanad, Amparo Santamaria, et al.
Therapeutic Advances in Hematology|May 8, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS StudyDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 22, 2022
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A - A modified Delphi consensus by the ADVANCE Working GroupRobert Klamroth, Cihan Ay, Philippe De Moerloose, et al.
Thrombosis and Haemostasis|February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect StudyRi J Liesner, Aby Abraham, Carmen Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 6, 2024
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical AppraisalManuela Albisetti, Jesús Ardila, Jan Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 9, 2024
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand DiseaseMark W Skinner, Manuela Albisetti, Jesús Ardila, et al.
Pageof 5